Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$77.90
At close: May 21 EDT
$77.90
0.000.00%
Pre-Market: 4:49 PM EDT
Comments
Loading...
MetLife Analyst Ratings and Price Targets | NYSE:MET | Benzinga
MetLife Inc has a consensus price target of $87.68 based on the ratings of 20 analysts. The high is $99 issued by Morgan Stanley on May 19, 2025. The low is $71 issued by Barclays on November 17, 2023. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Barclays on May 19, 2025, May 6, 2025, and April 11, 2025, respectively. With an average price target of $93.67 between Morgan Stanley, Wells Fargo, and Barclays, there's an implied 20.24% upside for MetLife Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
Barclays
Keefe, Bruyette & Woods
UBS
1calculated from analyst ratings
Analyst Ratings for MetLife
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | Buy Now | 27.09% | Morgan Stanley | Nigel Dally70% | $94 → $99 | Maintains | Overweight | Get Alert |
| 05/06/2025 | Buy Now | 20.67% | Wells Fargo | Elyse Greenspan76% | $91 → $94 | Maintains | Overweight | Get Alert |
| 04/11/2025 | Buy Now | 12.97% | Barclays | Alex Scott65% | $95 → $88 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 16.82% | Wells Fargo | Elyse Greenspan76% | $97 → $91 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 20.67% | Morgan Stanley | Nigel Dally70% | $109 → $94 | Maintains | Overweight | Get Alert |
| 04/09/2025 | Buy Now | 21.95% | Keefe, Bruyette & Woods | Ryan Krueger72% | $98 → $95 | Maintains | Outperform | Get Alert |
| 04/02/2025 | Buy Now | 25.8% | UBS | Brian Meredith78% | $94 → $98 | Maintains | Buy | Get Alert |
| 04/02/2025 | Buy Now | 20.67% | Piper Sandler | John Barnidge72% | $92 → $94 | Maintains | Overweight | Get Alert |
| 04/02/2025 | Buy Now | 10.4% | JP Morgan | Jimmy Bhullar66% | $88 → $86 | Maintains | Overweight | Get Alert |
| 02/28/2025 | Buy Now | 39.92% | Morgan Stanley | Nigel Dally70% | $101 → $109 | Maintains | Overweight | Get Alert |
| 02/19/2025 | Buy Now | 24.52% | Wells Fargo | Elyse Greenspan76% | $92 → $97 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 25.8% | Keefe, Bruyette & Woods | Ryan Krueger72% | $100 → $98 | Maintains | Outperform | Get Alert |
| 02/07/2025 | Buy Now | 21.95% | Barclays | Alex Scott65% | $96 → $95 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 24.52% | BMO Capital | Jack Matten44% | → $97 | Initiates | → Market Perform | Get Alert |
| 01/14/2025 | Buy Now | 18.1% | Wells Fargo | Elyse Greenspan76% | $93 → $92 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 12.97% | JP Morgan | Jimmy Bhullar66% | $86 → $88 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | 23.23% | Barclays | Alex Scott65% | $90 → $96 | Maintains | Overweight | Get Alert |
| 11/27/2024 | Buy Now | 27.09% | TD Cowen | Daniel Bergman55% | $97 → $99 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 19.38% | Wells Fargo | Elyse Greenspan76% | $92 → $93 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | 15.53% | Barclays | Alex Scott65% | $91 → $90 | Maintains | Overweight | Get Alert |
| 10/10/2024 | Buy Now | 18.1% | Wells Fargo | Elyse Greenspan76% | $86 → $92 | Maintains | Overweight | Get Alert |
| 10/09/2024 | Buy Now | 24.52% | TD Cowen | Daniel Bergman55% | → $97 | Initiates | → Buy | Get Alert |
| 10/02/2024 | Buy Now | 18.1% | Piper Sandler | John Barnidge72% | $85 → $92 | Maintains | Overweight | Get Alert |
| 09/27/2024 | Buy Now | 21.95% | Jefferies | Suneet Kamath77% | $89 → $95 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | 16.82% | Barclays | Alex Scott65% | → $91 | Initiates | → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 9.11% | Morgan Stanley | Nigel Dally70% | $86 → $85 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | 10.4% | Wells Fargo | Elyse Greenspan76% | $85 → $86 | Maintains | Overweight | Get Alert |
| 08/01/2024 | Buy Now | 23.23% | B of A Securities | Joshua Shanker75% | $99 → $96 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | 14.25% | Citigroup | Michael Ward77% | $83 → $89 | Maintains | Buy | Get Alert |
| 07/18/2024 | Buy Now | 10.4% | Jefferies | Suneet Kamath77% | $83 → $86 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 6.55% | Morgan Stanley | Nigel Dally70% | $82 → $83 | Maintains | Overweight | Get Alert |
| 07/08/2024 | Buy Now | 9.11% | Keefe, Bruyette & Woods | Ryan Krueger72% | $86 → $85 | Maintains | Outperform | Get Alert |
| 07/02/2024 | Buy Now | 10.4% | JP Morgan | Jimmy Bhullar66% | $81 → $86 | Maintains | Overweight | Get Alert |
| 06/28/2024 | Buy Now | 6.55% | Jefferies | Suneet Kamath77% | $88 → $83 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 2.7% | Argus Research | Kevin Heal63% | $77 → $80 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 9.11% | Wells Fargo | Elyse Greenspan76% | $86 → $85 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 10.4% | Keefe, Bruyette & Woods | Ryan Krueger72% | $87 → $86 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | 5.26% | Piper Sandler | John Barnidge72% | $85 → $82 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 5.26% | Morgan Stanley | Nigel Dally70% | $80 → $82 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 10.4% | Wells Fargo | Elyse Greenspan76% | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 11.68% | Keefe, Bruyette & Woods | Ryan Krueger72% | $82 → $87 | Maintains | Outperform | Get Alert |
| 04/05/2024 | Buy Now | 9.11% | Piper Sandler | John Barnidge72% | $74 → $85 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | 6.55% | Wells Fargo | Elyse Greenspan76% | $85 → $83 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | 5.26% | UBS | Brian Meredith78% | $87 → $82 | Maintains | Buy | Get Alert |
| 01/10/2024 | Buy Now | 11.68% | UBS | Brian Meredith78% | $84 → $87 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | 2.7% | Goldman Sachs | Alex Scott65% | $70 → $80 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | 2.7% | Goldman Sachs | Alex Scott65% | → $80 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2023 | Buy Now | -1.16% | Keefe, Bruyette & Woods | Ryan Krueger72% | $79 → $77 | Maintains | Outperform | Get Alert |
| 11/17/2023 | Buy Now | -8.86% | Barclays | Tracy Benguigui59% | → $71 | Reinstates | → Overweight | Get Alert |
| 11/02/2023 | Buy Now | 2.7% | Morgan Stanley | Nigel Dally70% | $79 → $80 | Maintains | Overweight | Get Alert |
| 10/06/2023 | Buy Now | 5.26% | JP Morgan | Jimmy Bhullar66% | $85 → $82 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | -7.57% | Jefferies | Suneet Kamath77% | $58 → $72 | Upgrade | Hold → Buy | Get Alert |
| 08/18/2023 | Buy Now | 1.41% | Morgan Stanley | Nigel Dally70% | $78 → $79 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 6.55% | Wells Fargo | Elyse Greenspan76% | $82 → $83 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | -1.16% | Argus Research | Kevin Heal63% | $70 → $77 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | 3.98% | Citigroup | Michael Ward77% | $76 → $81 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -5.01% | RBC Capital | Mark Dwelle82% | $70 → $74 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 0.13% | Morgan Stanley | Nigel Dally70% | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 5.26% | Wells Fargo | Elyse Greenspan76% | $75 → $82 | Maintains | Overweight | Get Alert |
| 06/15/2023 | Buy Now | -2.44% | Citigroup | Michael Ward77% | $85 → $76 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | 2.7% | Keefe, Bruyette & Woods | Ryan Krueger72% | $86 → $80 | Reiterates | → Outperform | Get Alert |
| 06/02/2023 | Buy Now | 0.13% | Morgan Stanley | Nigel Dally70% | $80 → $78 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | -16.56% | RBC Capital | Mark Dwelle82% | $68 → $65 | Maintains | Outperform | Get Alert |
| 05/26/2023 | Buy Now | -3.72% | Wells Fargo | Elyse Greenspan76% | $72 → $75 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | -12.71% | RBC Capital | Mark Dwelle82% | $76 → $68 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | -2.44% | RBC Capital | Mark Dwelle82% | $83 → $76 | Maintains | Outperform | Get Alert |
| 04/12/2023 | Buy Now | 1.41% | Barclays | Tracy Benguigui59% | $83 → $79 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | 2.7% | Morgan Stanley | Nigel Dally70% | $90 → $80 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -5.01% | Piper Sandler | John Barnidge72% | $82 → $74 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -7.57% | Wells Fargo | Elyse Greenspan76% | $84 → $72 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -16.56% | Goldman Sachs | Alex Scott65% | $79 → $65 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 15.53% | Morgan Stanley | Nigel Dally70% | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | 6.55% | Wells Fargo | Elyse Greenspan76% | $81 → $83 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 12.97% | Morgan Stanley | Nigel Dally70% | $87 → $88 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | 0.13% | Goldman Sachs | Alex Scott65% | $80 → $78 | Downgrade | Buy → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 2.7% | JP Morgan | Jimmy Bhullar66% | $77 → $80 | Maintains | Overweight | Get Alert |
| 12/09/2022 | Buy Now | 5.26% | Jefferies | Suneet Kamath77% | $86 → $82 | Downgrade | Buy → Hold | Get Alert |
| 11/17/2022 | Buy Now | 11.68% | Morgan Stanley | Nigel Dally70% | $85 → $87 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | -1.16% | JP Morgan | Jimmy Bhullar66% | $74 → $77 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 9.11% | Morgan Stanley | Nigel Dally70% | $83 → $85 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | -5.01% | Wells Fargo | Elyse Greenspan76% | $75 → $74 | Maintains | Overweight | Get Alert |
| 09/22/2022 | Buy Now | — | Raymond James | Wilma Burdis69% | — | Initiates | → Market Perform | Get Alert |
| 08/22/2022 | Buy Now | -1.16% | Credit Suisse | Andrew Kligerman70% | $68 → $77 | Maintains | Outperform | Get Alert |
| 08/17/2022 | Buy Now | 6.55% | Morgan Stanley | Nigel Dally70% | $79 → $83 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 1.41% | Morgan Stanley | Nigel Dally70% | $78 → $79 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | -3.72% | Barclays | Tracy Benguigui59% | $79 → $75 | Maintains | Overweight | Get Alert |
| 07/06/2022 | Buy Now | 2.7% | Evercore ISI Group | Thomas Gallagher57% | $81 → $80 | Maintains | Outperform | Get Alert |
| 07/06/2022 | Buy Now | 0.13% | Morgan Stanley | Nigel Dally70% | $80 → $78 | Maintains | Overweight | Get Alert |
| 06/23/2022 | Buy Now | -5.01% | Wolfe Research | Michael Zaremski73% | $70 → $74 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/24/2022 | Buy Now | -1.16% | Citigroup | Michael Ward77% | → $77 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for MetLife (MET) stock?
The latest price target for MetLife (NYSE:MET) was reported by Morgan Stanley on May 19, 2025. The analyst firm set a price target for $99.00 expecting MET to rise to within 12 months (a possible 27.09% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MetLife (MET)?
The latest analyst rating for MetLife (NYSE:MET) was provided by Morgan Stanley, and MetLife maintained their overweight rating.
When was the last upgrade for MetLife (MET)?
The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.
When was the last downgrade for MetLife (MET)?
The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.
When is the next analyst rating going to be posted or updated for MetLife (MET)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
Is the Analyst Rating MetLife (MET) correct?
While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $94.00 to $99.00. The current price MetLife (MET) is trading at is $77.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
